Table: Daito -Q1 group results

Daito Pharmaceutical

13/10/2020 07:00

Oct 13 (Reuters)- 
             Daito Pharamaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Aug 31, 2020        Aug 31, 2019     May 31, 2021 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             13.70               11.66            47.50    
                 (+17.5 pct)         (+19.7 pct)      (+5.6 pct)  
  Operating          1.95                1.36             4.95    
                 (+43.5 pct)         (+24.0 pct)      (-7.6 pct)  
  Recurring          1.97                1.39             5.00    
                 (+41.1 pct)         (+22.0 pct)      (-8.5 pct)  
  Net                1.32              920 mln            3.40    
                 (+43.6 pct)         (+18.0 pct)      (-13.8 pct) 
  EPS             98.08 yen           73.55 yen       252.96 yen  
  Ann Div                             46.00 yen        46.00 yen  
  -Q2 div                             20.00 yen        23.00 yen  
  -Q4 div                             26.00 yen        23.00 yen  
  
  NOTE - Daito Pharamaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T